Giselle A. Suero Abreu, MD PhD (@gisellesa_mdphd) 's Twitter Profile
Giselle A. Suero Abreu, MD PhD

@gisellesa_mdphd

Cardiology fellow @MGHHeartHealth @mghecho @mghimaging @Harvardmed 🇩🇴 Interested in #CardioOnc 🫀💉💊 #cvImaging #🚺🫀Health #Opinions=my own. RT≠endorsement

ID: 837690674250121217

linkhttps://tinyurl.com/SueroAbreuGoogleScholar calendar_today03-03-2017 15:46:35

1,1K Tweet

1,1K Followers

1,1K Following

JACC Journals (@jaccjournals) 's Twitter Profile Photo

In cancer patients on anticoagulants for ≥6 months: 🔹Reduced-dose #apixaban was non-inferior to full-dose for preventing recurrent #VTE 🔹Reduced dose resulted in fewer clinically relevant bleeding #ACC25 #JACCJournals #CardioOnc #cvCoah Mahé Isabelle

Giselle A. Suero Abreu, MD PhD (@gisellesa_mdphd) 's Twitter Profile Photo

Recap #ACC25 #AF in cancer patients by Daniel Addison, MD ✅ Driven by inflammation, therapies & CV risks ⚠️ Worsens survival 🩺 Novel therapies linked to AF: ▪️ BTK inhibitors (i.e ibrutinib) ▪️ ICI, CAR-T, BiTE therapies 🔎 #whyCMR predicts outcomes in ibrutinib-associated AF

Recap #ACC25 #AF in cancer patients by <a href="/md_addison/">Daniel Addison, MD</a> 

✅ Driven by inflammation, therapies &amp; CV risks

⚠️ Worsens survival

🩺 Novel therapies linked to AF:
▪️ BTK inhibitors (i.e ibrutinib)
▪️ ICI, CAR-T, BiTE therapies 

🔎 #whyCMR predicts outcomes in ibrutinib-associated AF
Raul Cordoba, MD, PhD (@drraulcordoba) 's Twitter Profile Photo

#Cardiotoxicity of #CARTcell Antineoplastic Therapies: ⁦JACC Journals⁩ #JACCCardioOnc #CardioOnc #cardiology #hematology #lymsm sciencedirect.com/science/articl…

Giselle A. Suero Abreu, MD PhD (@gisellesa_mdphd) 's Twitter Profile Photo

#ACC2025 #CardioOnc session on starting soon! 🤔- Are we OK with some treatment-related heart failure, hypertension? 🤔- Should we rechallenge some patients post-ICI myocarditis? Join us to learn more about permissive cardiotoxicity! American College of Cardiology JACC Journals

#ACC2025 #CardioOnc session on starting soon! 

🤔- Are we OK with some treatment-related heart failure, hypertension?  

🤔- Should we rechallenge some patients post-ICI myocarditis?

Join us to learn more about permissive cardiotoxicity!

<a href="/ACCinTouch/">American College of Cardiology</a> 
<a href="/JACCJournals/">JACC Journals</a>
Mike Fradley, MD (@dr_mike_fradley) 's Twitter Profile Photo

Lenvatinib is associated with increased CV events ✅ most common CV events are hypertension and HF ✅ older age significantly associated with incident CV events #cardioonc #jacccardioonc #acc25

Lenvatinib is associated with increased CV events
✅ most common CV events are hypertension and HF
✅ older age significantly associated with incident CV events

#cardioonc #jacccardioonc #acc25
Novi Yanti Sari (@slumberbell) 's Twitter Profile Photo

#CV outcomes in patients with ICI-related #myocarditis ?🫀 👥101 patients with irMyocarditis: 📍31.7% also had irMyopathy 📍having both➡️ Higher troponin, CK and more arrhythmias 📍isolated irMyocarditis ➡️ Higher NTproBNP, lower EF & more #HF Read more:

#CV outcomes in patients with ICI-related #myocarditis ?🫀 

👥101 patients with irMyocarditis:
📍31.7% also had irMyopathy
📍having both➡️  Higher troponin, CK and more arrhythmias
📍isolated irMyocarditis ➡️ Higher NTproBNP, lower EF &amp; more #HF

Read more:
Giselle A. Suero Abreu, MD PhD (@gisellesa_mdphd) 's Twitter Profile Photo

#ACC25 #CardioOnc Don’t miss these JACC Journals #JACCCO simultaneous publications on ICI myocarditis. ✅ Original research on CV outcomes in ICI-myocarditis tinyurl.com/5n79fh7b ✅ Clinical case on rechallenge post-ICI myocarditis: tinyurl.com/5x7wnhmn

#ACC25 #CardioOnc

Don’t miss  these  <a href="/JACCJournals/">JACC Journals</a> #JACCCO simultaneous publications on ICI myocarditis. 

✅ Original research on CV outcomes in ICI-myocarditis
tinyurl.com/5n79fh7b

✅ Clinical case on rechallenge
 post-ICI myocarditis:
tinyurl.com/5x7wnhmn
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Congratulations to Bonnie Ky, MD, MSCE, FACC on winning the 2025 Distinguished Scientist Award (Translational Domain)! As a leader in #CardioOnc, her work is shaping the future of the field. #ACC25 #JACCCardioOnc @jaccjournals @pennthalheimer youtube.com/watch?v=I_meTO…